FTC Again Confirms That Antitrust Law Encourages ACO Formation


Once again, the staff of the Federal Trade Commission (FTC) has rebutted calls by physician groups that state legislation is needed to allow independent physicians to collaborate. The FTC staff disputed the physicians' assertion that the antitrust laws are a barrier to the formation of efficient collaborations benefiting consumers. In support of legislation introduced in Connecticut, eight medical organizations representing more than 9,000 Connecticut physicians claimed that "federal antitrust laws prohibit Connecticut physicians from collective discussions about certain critical aspects of care coordination," including the kinds of negotiations necessary to form ACOs. "This premise," according to the FTC staff, "is simply and categorically wrong." The FTC submitted a letter to the Connecticut legislature urging the legislature to reject the legislation sought by the physicians.

Well before the passage of the Patient Protection and Affordable Care Act (ACA) and its introduction of Medicare's Shared Savings Programs, the FTC and DOJ (Antitrust Agencies) provided general guidance on collaborations among competitors, issued joint statements specifically geared toward the application of the antitrust laws to the healthcare industry, including physician network joint ventures and other provider collaborations, and made public opinion letters regarding the antitrust treatment of proposed healthcare collaborations. After the passage of the ACA, the federal Antitrust Agencies and CMS even worked together to develop policies that encourage participation in ACOs and ensure coordination among and between the agencies.

The Antitrust Agencies also released a joint statement explaining their enforcement policy approach to ACOs "to ensure that health care providers have the antitrust clarity and guidance needed to form procompetitive ACOs that participate in both Medicare and commercial markets." The Antitrust Agencies even established a process for ACOs to seek expedited review if they have concerns about antitrust risk. In April, for example, the Antitrust Agencies released a summary of their activities in this area, noting that they received two requests for voluntary expedited review and fielded more than thirty questions.

In the words of the FTC, "the antitrust laws do not stand in the way of health care providers in Connecticut" or elsewhere "who form ACOs or other collaborative arrangements that are likely to reduce costs and benefit health care consumers through improved efficiency and improved coordination of care."

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© BakerHostetler | Attorney Advertising

Written by:


BakerHostetler on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.